Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Chestnut, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Chestnut patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Chestnut: Texas Weight Loss - North Austin, Texas Weight Loss - South Austin and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Wegovy seen from Chestnut, without the jargon. Wegovy was designed from the start for weight management, with a target dose higher than Ozempic's - hence its dedicated indication.
Pregnancy and breastfeeding are among the situations where these treatments are not indicated. Certain histories (pancreatitis, some familial thyroid cancers) point toward other options: hence the importance of the medical questionnaire.
Wegovy belongs to the 'GLP-1 agonist (brand of semaglutide, weight indication)' class and is given as a weekly subcutaneous injection. Typical dosing: titrated up to the 2.4 mg/week target dose, higher than Ozempic's. Local landmark: Texas Weight Loss - North Austin (11139 N Interstate Hwy 35 Ste 120, Austin, TX 78753), rated 4.9/5 across 453 reviews. In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
It is the same molecule (semaglutide), but Wegovy goes up to 2.4 mg/week versus 2.0 mg max for Ozempic - a dose built for weight loss, which is why it is approved for that indication.
Coverage varies widely by plan; without coverage, many patients compare it to compounded semaglutide, which is far cheaper.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.